Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
1987-12-1
|
pubmed:abstractText |
Seven female and three male outpatients (mean age 45, range 37-54), suffering from gastroesophageal reflux underwent therapy with clebopride, a new selective antidopaminergic agent. Before and after treatment (1 mg b.i.d. for ten days) 24 h-continuous monitoring of esophageal pH was done. Clebopride significantly lowered the number and the extension of gastroesophageal acid refluxes.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0026-4806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1421-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3670685-Adult,
pubmed-meshheading:3670685-Antiemetics,
pubmed-meshheading:3670685-Benzamides,
pubmed-meshheading:3670685-Female,
pubmed-meshheading:3670685-Gastroesophageal Reflux,
pubmed-meshheading:3670685-Humans,
pubmed-meshheading:3670685-Hydrogen-Ion Concentration,
pubmed-meshheading:3670685-Male,
pubmed-meshheading:3670685-Middle Aged,
pubmed-meshheading:3670685-Monitoring, Physiologic
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Medical therapy of gastroesophageal reflux. Evaluation of the activity of clebopride by continuous intraluminal pH measurement].
|
pubmed:affiliation |
Clinica Medica, Università di Ferrara.
|
pubmed:publicationType |
Journal Article,
English Abstract
|